As of Feb 16
| +1.41 / +2.00%|
The 22 analysts offering 12-month price forecasts for CVS Health Corp have a median target of 90.00, with a high estimate of 100.00 and a low estimate of 73.00. The median estimate represents a +25.17% increase from the last price of 71.90.
The current consensus among 26 polled investment analysts is to Buy stock in CVS Health Corp. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.